1. Home
  2. CCCC vs UIS Comparison

CCCC vs UIS Comparison

Compare CCCC & UIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo C4 Therapeutics Inc.

CCCC

C4 Therapeutics Inc.

HOLD

Current Price

$2.02

Market Cap

240.3M

Sector

Health Care

ML Signal

HOLD

Logo Unisys Corporation New

UIS

Unisys Corporation New

HOLD

Current Price

$2.85

Market Cap

260.2M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
CCCC
UIS
Founded
2015
1942
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
240.3M
260.2M
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
CCCC
UIS
Price
$2.02
$2.85
Analyst Decision
Strong Buy
Buy
Analyst Count
5
5
Target Price
$7.25
$5.88
AVG Volume (30 Days)
2.0M
738.0K
Earning Date
11-06-2025
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$30,108,000.00
$1,921,000,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$0.20
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.09
$2.37
52 Week High
$4.26
$7.54

Technical Indicators

Market Signals
Indicator
CCCC
UIS
Relative Strength Index (RSI) 35.66 48.80
Support Level $2.00 $2.77
Resistance Level $2.69 $3.10
Average True Range (ATR) 0.17 0.11
MACD -0.07 0.03
Stochastic Oscillator 7.10 43.96

Price Performance

Historical Comparison
CCCC
UIS

About CCCC C4 Therapeutics Inc.

C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patients' lives. The Company is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. Its degrader medicines are designed to harness the body's natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, and drug undruggable targets and improve patient outcomes. Its pipeline is Cemsidomide, CFT1946, and CFT8919.

About UIS Unisys Corporation New

Unisys Corp is engaged in the provision of technology solutions for clients across the government, financial services, and commercial markets. It operates through three business segments: Digital Workplace Solutions (DWS),Cloud, Applications & Infrastructure Solutions (CA&I), and Enterprise Computing Solutions (ECS). DWS provides workplace solutions featuring intelligent workplace services, proactive experience management and collaboration tools to support business growth. CA&I which provides digital transformation in the areas of cloud migration and management. ECS which provides solutions that harness secure, high-intensity enterprise computing and enable digital services through software-defined operating environments. Majority of revenue is from ECS segment.

Share on Social Networks: